PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

Inclusion Criteria

• •Patients must have a biopsy-proven diagnosis of high risk, very high risk, or locally advanced prostate cancer
• •Patients must have a diagnosis of high risk, very high risk, or locally advanced prostate cancer per NCCN Guidelines (T3-T4 disease)
• •Patients are healthy enough to be deemed surgical candidates with an ECOG performance status of 0-2
• •Patients must be age ≥ 18 years
• •Patients must agree to use adequate contraception (e.g. barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 30 days following completion of the imaging
• •Patients must have the ability to understand and the willingness to sign a written informed consent prior to registration on study